Table 3

Mean predicted Δ SHS for patients in remission, LDA, MDA and HDA

RemissionLDAMDAHDA
Mean (95% CI)Mean (95% CI)Mean (95% CI)Mean (95% CI)
DAS3.49 (−0.06 to 7.04)5.50 (2.35 to 8.66)7.34 (4.09 to 10.60)11.70 (7.39 to 16.01)
DAS CRP4.08 (0.95 to 7.21)5.44 (2.34 to 8.55)6.69 (3.58 to 9.81)11.72 (7.09 to 16.35)
DAS283.57 (0.12 to 7.02)4.61 (1.43 to 7.79)6.88 (3.77 to 9.98)10.83 (6.83 to 14.83)
DAS28 CRP3.54 (−0.03 to 7.10)5.54 (2.34 to 8.74)8.05 (4.80 to 11.30)13.18 (8.51 to 17.84)
SDAI4.01 (0.76 to 7.26)4.67 (1.37 to 7.97)7.39 (4.16 to 10.61)11.48 (7.25 to 15.71)
CDAI3.85 (0.64 to 7.06)4.66 (1.41 to 7.91)7.40 (4.18 to 10.61)10.95 (6.89 to 15.00)
DAS 0–13.41 (−0.05 to 6.87)5.45 (2.33 to 8.57)7.21 (4.01 to 10.42)12.66 (8.21 to 17.12)
DAS TJC533.54 (0.17 to 6.90)4.78 (1.45 to 8.11)6.89 (3.69 to 10.08)9.92 (6.02 to 13.82)
DAS TJC443.64 (0.28 to 7.00)4.92 (1.60 to 8.24)7.16 (3.96 to 10.36)10.24 (6.25 to 14.23)
  • Covariates and factors appearing in the model are fixed at the following values: previous SHS 10.3; year 2.8; age 53.8; treatment group 1; anti-CCP positive patients; female gender.

  • CDAI, Clinical Disease Activity Index; CRP, C reactive protein; DAS, Disease Activity Score; DAS 0–1, Disease Activity Score with RAI 0–1; DAS28, Disease Activity Score in 28 joints; HDA, high disease activity; LDA, low disease activity; MDA, moderate disease activity; SDAI, Simplified Disease Activity Index; SHS, Sharp/van der Heijde score; TJC44, tender joint count 44 joints; TJC53, tender joint count 53 joints.